MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness
NCT01464216 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2022-06-21
Summary
The purpose of the study is to combine and correlate data from morphological and functional MRI, molecular signatures of tumor hypoxia, the presence of micrometastases and tumor hypoxia with the goal being predicting of prostate cancer aggressiveness.
Conditions
- Prostatic Neoplasms
- Genital Neoplasms, Male
- Prostatic Diseases
Sponsors & Collaborators
-
Radboud University Medical Center
collaborator OTHER -
Oslo University Hospital
lead OTHER
Eligibility
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-10-31
- Primary Completion
- 2022-12-31
- Completion
- 2030-12-31
Countries
- Norway
Study Locations
More Related Trials
-
Diagnostic Imaging of Bone Metastases in Prostate Cancer Patients
NCT03134261 ·Status: UNKNOWN ·Phase: NA
-
MR Radiomic Features in Prostate Cancer
NCT04219059 ·Status: COMPLETED
-
Development and Validation of Novel MRI Methods for the Detection of Prostate Cancer Aggressiveness
NCT02545881 ·Status: UNKNOWN
-
CombIning advaNces in imagiNg With biOmarkers for improVed Diagnosis of Aggressive prosTate cancEr
NCT02689271 ·Status: COMPLETED
-
Magnetic Resonance Imaging (MRI) With Hyperpolarized Pyruvate (13C) as Diagnostic Tool in Advanced Prostate Cancer
NCT04346225 ·Status: RECRUITING ·Phase: PHASE2
-
Preoperative Magnetic Resonance (MR) Imaging of Prostate Cancer
NCT01347320 ·Status: COMPLETED ·Phase: NA
-
Molecular PET/MR Imaging in Vivo Validation of Biomarker for Human Prostate Cancer
NCT03451812 ·Status: UNKNOWN
-
Magnetic Resonance (MR) Imaging With Hyperpolarized Pyruvate (HP) (13C) in Castration-Resistant Prostate Cancer
NCT02911467 ·Status: TERMINATED ·Phase: PHASE1
-
Whole-Body Diffusion-Weighted Magnetic Resonance Imaging (MRI) as a Response Biomarker for Metastatic Prostate Cancer
NCT05078151 ·Status: UNKNOWN ·Phase: NA
-
PSMA-PET and MRI for Detection of Recurrent Prostate Cancer After Radical Treatment
NCT04298112 ·Status: COMPLETED
-
Magnetic Resonance Imaging to Evaluate Prostate Cancer
NCT00182624 ·Status: COMPLETED
-
Exploiting Risk-Based Risk Stratification in Early Prostate Cancer to Discriminate Progressors From Non-Progressors
NCT04340245 ·Status: ACTIVE_NOT_RECRUITING
-
Multiparametric MRI in Men With Prostate Cancer Undergoing Active Surveillance
NCT02526797 ·Status: ENROLLING_BY_INVITATION
-
Magnetic Resonance Imaging to Locate and Characterize Prostate Cancer
NCT00082147 ·Status: COMPLETED ·Phase: NA
-
Defining the Extent and Grade of Prostate Cancer Using Dynamic Contrast Enhanced Diffusion Weighted and BOLD MRI
NCT00242112 ·Status: COMPLETED ·Phase: NA
-
Radiomics of Treatment-naive Prostate Cancer Patients on Multiparametric MRI for Risk Stratification and Treatment Outcomes Predictions
NCT06126172 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Localising Occult Prostate Cancer Metastases With Advanced Imaging TEchniques
NCT02935816 ·Status: UNKNOWN
-
Using Magnetic Resonance Imaging (MRI) to Guide Differential-Dose Prostate Brachytherapy
NCT01913197 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Can MRI of the Prostate Combined With a Radiomics Evaluation Determine the Invasive Capacity of a Tumour
NCT05024162 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Treatment Response Using Multiparametric MRI After Prostate Radiotherapy
NCT02312401 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Characterize Tumor Hypoxia by Magnetic Resonance Imaging
NCT03987568 ·Status: WITHDRAWN ·Phase: NA
-
Magnetic Resonance Imaging in Detecting Cancer Progression in Patients With Early Stage Prostate Cancer Undergoing Active Surveillance
NCT00796874 ·Status: WITHDRAWN ·Phase: NA
-
Novel MRI Assessment of Prostate Cancer VALIDATE-PRO
NCT05017181 ·Status: UNKNOWN
-
Positron Emission Tomography and Magnetic Resonance Imaging for Prostate Cancer
NCT00924313 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Potential Use of BOLD MRI as a Noninvasive Measure of Tumor Hypoxia in Prostate Cancer
NCT00242073 ·Status: COMPLETED ·Phase: NA